|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
GPS | Saksena Asheesh | Chief Growth Officer | Jan 11 | Option Exercise | 0.00 | 44,663 | 0 | 78,954 | Jan 12 06:30 PM |
GPS | Saksena Asheesh | Chief Growth Officer | Mar 15 | Option Exercise | 0.00 | 5,763 | 0 | 37,148 | Mar 16 07:27 PM |
GPS | Saksena Asheesh | Chief Growth Officer | Jan 11 | Option Exercise | 0.00 | 44,662 | 0 | 45,639 | Jan 12 05:49 PM |
BBY | Saksena Asheesh | President, Best Buy Health | May 26 | Sale | 80.84 | 12,000 | 970,134 | 122,921 | May 28 04:59 PM |
BBY | Saksena Asheesh | President, Best Buy Health | May 22 | Sale | 77.49 | 21,976 | 1,702,960 | 134,921 | May 26 06:38 PM |
BBY | Saksena Asheesh | President, Best Buy Health | Apr 15 | Sale | 67.08 | 14 | 939 | 114,457 | Apr 17 05:17 PM |
BBY | Saksena Asheesh | President, Best Buy Health | Mar 23 | Sale | 51.75 | 1,523 | 78,820 | 113,986 | Mar 24 05:55 PM |
BBY | Saksena Asheesh | President, Best Buy Health | Mar 13 | Sale | 56.88 | 1,466 | 83,393 | 118,232 | Mar 17 06:48 PM |
BBY | Saksena Asheesh | President, Best Buy Health | Mar 16 | Sale | 54.42 | 2,723 | 148,180 | 115,509 | Mar 17 06:48 PM |
BBY | Saksena Asheesh | Chief Strategic Growth Officer | Sep 05 | Sale | 80.07 | 26,309 | 2,106,595 | 51,169 | Sep 06 04:24 PM |
BBY | Saksena Asheesh | Chief Strategic Growth Officer | Jun 14 | Sale | 73.69 | 18,570 | 1,368,442 | 77,478 | Jun 15 04:44 PM |
BBY | Saksena Asheesh | Chief Strategic Growth Officer | Mar 14 | Sale | 70.50 | 1,533 | 108,070 | 95,701 | Mar 15 05:43 PM |
BBY | Saksena Asheesh | Chief Strategic Growth Officer | Jun 16 | Sale | 55.66 | 22,255 | 1,238,602 | 82,440 | Jun 20 04:13 PM |
BBY | Saksena Asheesh | Chief Strategic Growth Officer | Jun 14 | Sale | 57.08 | 18,706 | 1,067,813 | 104,695 | Jun 15 04:20 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite